1 Stock Helping Revolutionize Diabetes Monitoring
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 16, 10:41AM CDT
More than 365 million people have diabetes worldwide and estimates suggest that the number of diabetics will grow to more than half a billion people around the globe by 2030. As a result, the market for new, innovative therapies that improve how...
'Mad Money' Lightning Round: Delta Is Flying to $40
at The Street - Wed Apr 16, 5:00AM CDT
Cramer says sell LinkedIn and Arena Pharmaceuticals but buy Constellation Brands.
Jim Cramer's 'Mad Money' Recap: Fear and Loathing on Wall Street
at The Street - Tue Apr 15, 7:08PM CDT
That's what professional money managers are feeling as they try and make sense of the today's market action, Cramer says.
Shares of DXCM Down 13.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 11, 9:46AM CDT
SmarTrend identified a Downtrend for DexCom (NASDAQ
Delcath Systems Shares Tank on Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 1:50PM CDT
Delcath has been going through a rough patch after it failed to win approval from U.S. Food and Drug Administration (FDA) for its Melblez liver cancer therapy device.
Why DexCom (DXCM) Stock Is Higher Today
at The Street - Thu Apr 10, 8:50AM CDT
Shares of DexCom (DXCM) are up this morning after Sterne Agee upgraded the medical device company to "buy" from "neutral" with a price target of $50.
Upgrade Alert for DexCom (DXCM)
Comtex SmarTrend(R) - Thu Apr 10, 6:58AM CDT
DexCom (NASDAQ
DexCom (DXCM) is now in Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 7:55AM CDT
DexCom (DXCM) is now in Oversold Territory
Insider Trading Alert - ITMN, DXCM And MU Traded By Insiders
at The Street - Fri Apr 04, 10:30AM CDT
Stocks with insider trader activity include ITMN, DXCM and MU
DexCom Shares Fall on FDA Warning - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 2:30PM CDT
Since the revelation of the warning letter, DexCom's shares dropped 5.7% to close at $41.95 yesterday.
Balanced View on Cyberonics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 5:05PM CDT
Although revenues missed the mark, results reflected healthy year-over-year growth.
Balanced View on Haemonetics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 1:50PM CDT
On Mar 28, we issued an updated research report on Haemonetics Corporation.
Balanced View on Hologic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 1:50PM CDT
On Mar 27, we issued an updated research report on Hologic.
Momentum Indicators for Health Care Equities -- Research on ResMed, CareFusion, DENTSPLY Intl., and DexCom
PR Newswire - Wed Mar 26, 11:42AM CDT
The trading session on Tuesday, March 25, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,367.88, up 0.56% and the NASDAQ Composite closed at 4,234.27, up 0.19%. The S&P 500 finished the session 0.44% higher at 1,865.62. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, while the same has declined 1.64% in the last one month. Investor-Edge has initiated coverage on the following equities: ResMed Inc. (NYSE: RMD), CareFusion Corp. (NYSE: CFN), DENTSPLY International Inc. (NASDAQ: XRAY), and DexCom Inc. (NASDAQ: DXCM). Free technical research on RMD, CFN, XRAY, and DXCM can be downloaded upon signing up at:
DexCom Receives FDA Warning Letter for Administrative Deficiencies in its MDR Reporting
Business Wire - Tue Mar 25, 7:31AM CDT
DexCom, Inc. (NASDAQ
Why DexCom (DXCM) Could Be a Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 8:00AM CDT
If you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider DexCom.
FDA Clears Volcano Corp's iFR Modality - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 4:10PM CDT
Volcano Corporation recently received the U.S. FDA approval for the company's proprietary iFR (instant wave-Free Ratio) Modality.
Varian to Acquire Velocity Medical SW - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 3:50PM CDT
Post-acquisition, Varian expects its global sales, service, and support network will lead to better market penetration for the Velocity software.
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
Dexcom Supports NASCAR Driver Ryan Reed's American Diabetes Association Drive to Stop Diabetes(SM) Initiative
Business Wire - Wed Mar 05, 3:04PM CST
Dexcom, Inc., (NASDAQ